Core Viewpoint - Huabang Health (002004) is planning a non-public issuance of technology innovation exchangeable bonds to raise up to 1 billion RMB for debt repayment and other legal purposes [1] Group 1: Stock Performance - As of December 23, 2025, Huabang Health closed at 4.83 RMB, down 0.62% from the previous trading day [1] - The stock opened at 4.85 RMB, reached a high of 4.88 RMB, and a low of 4.81 RMB, with a trading volume of 91.92 million RMB and a turnover rate of 1.01% [1] Group 2: Bond Issuance - The company’s board approved a plan for a non-public issuance of technology innovation exchangeable bonds, targeting professional institutional investors [1] - The bond issuance will not exceed 1 billion RMB and will have a term of no more than 3 years, with the option to exchange for shares of Shandong Kaisheng New Materials Co., Ltd. [1] - The raised funds, after deducting issuance costs, will be used for repaying interest-bearing debts and other purposes compliant with legal regulations [1] - The issuance plan is subject to approval by the shareholders' meeting [1]
华邦健康(002004)披露非公开发行科技创新可交换公司债券公告,12月23日股价下跌0.62%